Oversea Chinese Banking Corp LTD Legend Biotech Corp Call Options Transaction History
Oversea Chinese Banking Corp LTD
- $3.03 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding LEGN
# of Institutions
212Shares Held
63.8MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$645 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$353 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$317 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$154 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$141 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $9.87B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...